Results 211 to 220 of about 5,799 (244)
بررسی میزان سطح سرمی لپتین و گرلین در بیماران تالاسمی ماژور و متوسط در مقایسه با افراد سالم [PDF]
بهمنیار, مریم +2 more
core
Association between hematological disorders and gallbladder stones: A review of current evidence. [PDF]
Qu ZJ, Wang YN, Liu YH, Duan RH.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology, 2004
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen +4 more
openaire +2 more sources
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen +4 more
openaire +2 more sources
Pediatric Clinics of North America, 2013
The thalassemia syndromes are hemoglobin disorders that result from significantly reduced or absent synthesis of either the α- or β-globin chains. The result is a chronic hemolytic anemia with ineffective erythropoiesis and bone marrow overstimulation.
Alissa, Martin, Alexis A, Thompson
openaire +2 more sources
The thalassemia syndromes are hemoglobin disorders that result from significantly reduced or absent synthesis of either the α- or β-globin chains. The result is a chronic hemolytic anemia with ineffective erythropoiesis and bone marrow overstimulation.
Alissa, Martin, Alexis A, Thompson
openaire +2 more sources
American Journal of Hematology, 1977
AbstractThe current concepts of α‐thalassemia including incidence, genetics, clinical spectrum and diagnosis are reviewed. Speculation concerning clinical application of the molecular biology of α‐thalassemia is also presented.
J G, Adams, M H, Steinberg
openaire +2 more sources
AbstractThe current concepts of α‐thalassemia including incidence, genetics, clinical spectrum and diagnosis are reviewed. Speculation concerning clinical application of the molecular biology of α‐thalassemia is also presented.
J G, Adams, M H, Steinberg
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2023
Edward J, Benz, Vijay G, Sankaran
openaire +2 more sources
Edward J, Benz, Vijay G, Sankaran
openaire +2 more sources

